Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ...

Early safety and visual performance signals were reported at 3 months from a first-in-human (FIH) clinical study evaluating ...

Dr. George Waring successfully performed the first FDA-approved implantation in the United States of the BVI FineVision® HP Trifocal Intraocular Lens ...

SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company, announced that it has entered into an agreement to ...

Consecutive patients with MA50 IOLs placed in the sulcus at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA, from 1997 to 2012 were identified. Inclusion criteria included patients ...

January 15, 2026 - PRESSADVANTAGE - Lucent Vision has published a new educational resource titled “What Practice Offers ...

The integration aligns with Arctic Vision’s strategy to expand its pipeline in ophthalmic areas with significant unmet needs.

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

—There is no perfect intraocular lens, but matching a patient with the lens that best meets their needs can help reduce postoperative dissatisfaction. Reviewed by Sarju Patel, MD, MPH, MSc, Director ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

NEW ORLEANS — A novel intraocular lens (IOL) appears to prevent negative dysphotopsia associated with cataract surgery, according to prospective studies in 100 patients. Negative dysphotopsia (ND), or ...